$62.70
+5.39 (+9.40%)
At Close: Jun 03, 2026
Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System
07:01am, Monday, 07'th Apr 2025
ASILOMAR, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announce
Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR
07:00am, Monday, 07'th Apr 2025
ASILOMAR, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announce
Bruker price target lowered to $50 from $75 at Citi
06:18am, Monday, 07'th Apr 2025
Citi lowered the firm's price target on Bruker to $50 from $75 and keeps a Buy rating on the shares as part of a Q1 preview for the life science tools and diagnostics group. The firm believes tariffs
Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain?
10:26am, Thursday, 03'rd Apr 2025
BRKR announces first successful customer installation of novel d-DNP Polarizer at UCSF.
Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR
07:00am, Wednesday, 02'nd Apr 2025
SAN FRANCISCO--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation today announced the introduction of its groundbreaking dissolution Dynamic Nuclear Polarization (d-DNP) Polarizer at the 2025 Hyperpo
Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM
09:01am, Thursday, 06'th Mar 2025
BRKR unveils X4 POSEIDON advanced XRM for 3D microscopy in industrial and scientific applications.
Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications
10:49am, Thursday, 27'th Feb 2025
KONTICH, Belgium--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Comp
Bruker Spatial Biology to Announce Groundbreaking Advances at AGBT 2025
08:01am, Friday, 21'st Feb 2025
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 Advances in Genome Biol
Bruker Appoints Laura Francis to its Board of Directors
08:00am, Friday, 21'st Feb 2025
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent dir
Bruker Announces Quarterly Dividend
07:00am, Friday, 21'st Feb 2025
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.0
Bruker Corporation to Present at Upcoming Investor Conferences
04:01pm, Thursday, 20'th Feb 2025
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Citi 2025 Unplugged Medtech a
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
06:46am, Friday, 14'th Feb 2025
Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.
Bruker Corporation (BRKR) Q4 2024 Earnings Call Transcript
03:22pm, Thursday, 13'th Feb 2025
Bruker Corporation (NASDAQ:BRKR ) Q4 2024 Results Conference Call February 13, 2025 8:30 AM ET Company Participants Joe Kostka - Director, Investor Relations Frank Laukien - President and CEO Gerald H
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say
12:01pm, Thursday, 13'th Feb 2025
Although the revenue and EPS for Bruker (BRKR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stree
Bruker (BRKR) Q4 Earnings and Revenues Surpass Estimates
09:25am, Thursday, 13'th Feb 2025
Bruker (BRKR) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.70 per share a year ago.
Sign In
Buy BRKR